Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00770 | PNU159682-EDA-Gly3 | |
| PNU159682-EDA-Gly3 is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via EDA-Gly3. | Inquiry | |
| BADC-00802 | PAC | 2158322-33-7 |
| PAC is a PROTAC with an ADC linker, intended to be conjugated to an antibody. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab). | Inquiry | |
| BADC-00803 | Cys-mcMMAD | |
| Cys-mcMMAD is a drug-linker conjugate for ADC. MMAD is a potent inhibitor of tubulin. | Inquiry | |
| BADC-00804 | DBCO-(PEG)3-VC-PAB-MMAE | |
| DBCO-(PEG)3-VC-PAB-MMAE is produced by MMAE conjugated to DBCO-(PEG)3-vc-PAB linker. Monomethyl auristatin E (MMAE) is a potent tubulin inhibitor. | Inquiry | |
| BADC-00805 | MAL-di-EG-Val-Cit-PAB-MMAE | |
| MAL-di-EG-Val-Cit-PAB-MMAE is a drug-linker conjugate containing the ADC linker MAL-di-EG-Val-Cit-PAB and the tubulin inhibitor MMAE. | Inquiry | |
| BADC-00806 | MAL-di-EG-Val-Cit-PAB-MMAF | |
| MAL-di-EG-Val-Cit-PAB-MMAF is a drug-linker conjugate containing the ADC linker MAL-di-EG-Val-Cit-PAB and the tubulin polymerization blocker MMAF. | Inquiry | |
| BADC-00807 | N3-PEG3-VC-PAB-MMAE | |
| N3-PEG3-VC-PAB-MMAE is a drug-linker conjugate containing the ADC linker N3-PEG3-VC-PAB and the tubulin inhibitor MMAE. | Inquiry | |
| BADC-00847 | CL2-SN-38 | 1036969-20-6 |
| CL2-SN-38 is a cleavable linker-based antibody-drug conjugate (ADC) containing the topoisomerase I inhibitor SN-38 and a maleimidocaproyl linker. | Inquiry | |
| BADC-00848 | MC-DM1 | 1375089-56-7 |
| MC-DM1 is a drug-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker MC to make antibody drug conjugate (ADC). | Inquiry | |
| BADC-00849 | Acetylene-linker-Val-Cit-PABC-MMAE | 1411977-95-1 |
| Acetylene-linker-Val-Cit-PABC-MMAE consists the ADCs linker (Acetylene-linker-Val-Cit-PABC) and potent tubulin inhibitor (MMAE), Acetylene-linker-Val-Cit-PABC-MMAE is an antibody drug conjugate. | Inquiry | |
| BADC-00850 | MC-VC-PABC-Aur0101 | 1438849-92-3 |
| MC-VC-PABC-Aur0101 is a drug-linker conjugate for ADC with potent antitumor activity by using Aur0101 (an auristatin microtubule inhibitor), linked via the ADC linker MC-VC-PABC. | Inquiry | |
| BADC-00851 | Tesirine | 1595275-62-9 |
| Tesirine (SG3249) is a drug-linker conjugates for ADC which is used in the treatment of several cancers. PBD Dimer is a DNA alkylating which inhibits DNA replication. | Inquiry | |
| BADC-00852 | Mc-Dexamethasone | 1618096-56-2 |
| Mc-Dexamethasone is a drug-linker conjugate for ADC. Mc-Dexamethasone is made toxin Dexamethasone (HY-14648) conjugated to the non-cleavable MC linker. Dexamethasone is a glucocorticoid receptor agonist. | Inquiry | |
| BADC-00853 | MC-VC-PABC-DNA31 | 1639352-03-6 |
| MC-VC-PABC-DNA31 is a drug-linker conjugate for ADC with potent antitumor activity by using DNA31 (a potent RNA polymerase inhibitor), linked via the ADC linker MC-VC-PABC. | Inquiry | |
| BADC-00854 | Mc-VC-PAB-SN38 | 1801838-28-7 |
| Mc-VC-PAB-SN38 consists a cleavable ADC linker (Mc-VC-PAB) and a DNA topoisomerase I inhibitor (SN38). Mc-VC-PAB-SN38 can be used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00855 | SuO-Glu-Val-Cit-PAB-MMAE | 1895916-24-1 |
| SuO-Glu-Val-Cit-PAB-MMAE consists a cleavable ADC linker (SuO-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00856 | MMAE-SMCC | 2021179-11-1 |
| MMAE-SMCC is a drug-linker conjugate for ADC. MMAE-SMCC is composed of a potent mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody drug conjugate. | Inquiry | |
| BADC-00857 | MC-Val-Cit-PAB-vinblastine | 2055896-92-7 |
| MC-Val-Cit-PAB-vinblastine is a drug-linker conjugate for ADC with potent antitumor activity by using vinblastine (an microtubule protein inhibitor), linked via the ADC linker MC-Val-Cit-PAB. | Inquiry | |
| BADC-00858 | MC-Val-Cit-PAB-rifabutin | 2055900-34-8 |
| MC-Val-Cit-PAB-rifabutin is a drug-linker conjugate for ADC with potent antitumor activity by using rifabutin (an DNA-dependent RNA polymerase inhibitor), linked via the ADC linker MC-Val-Cit-PAB. | Inquiry | |
| BADC-00859 | DGN549-C | 2058075-34-4 |
| DGN549-C consists a cleavable ADC linker valine-alanine (va) and PBD dimer. DGN549 is a novel DNA-alkylating cytotoxic payload and can be used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry |
